[SYRS] QoQ Quarter Result on 30-Sep-2024 [#Q3]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
31-Oct-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 72.58%
YoY- 84.07%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 0 0 0 386 3,762 2,833 2,954 -
PBT -6,396 -23,327 -3,708 -64,384 -40,143 -36,258 -23,789 -58.24%
Tax 0 0 291 10,883 -3,296 1,278 -8,865 -
NP -6,396 -23,327 -3,708 -64,384 -40,143 -36,258 -14,924 -43.06%
Tax Rate - - - - - - - -
Total Cost 6,396 23,327 3,708 64,770 43,905 39,091 17,878 -49.50%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 0.00 0.00 0.00 -16,679.79 -1,067.07 -1,279.84 -505.21 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.16 -0.59 -0.10 -2.18 -1.43 -1.30 -0.54 -55.45%
EPS Diluted -0.16 -0.59 -0.10 -2.18 -1.43 -1.30 -0.54 -55.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.